Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03272529 · ClinicalTrials.gov registry record
Simulated Rehearsal for Percutaneous Nephrolithotomy
A clinical trial of Nephrolithotomy, sponsored by University of Rochester.
- Completed
- Registry status
- 36
- Enrollment target
- 1
- Study location
NCT03272529: Completed study of Nephrolithotomy, sponsored by University of Rochester.
NCT03272529 is a study of Nephrolithotomy that has completed, run by University of Rochester. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03272529, a study of Nephrolithotomy, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Surgical simulation provides opportunities for surgeons to practice specific skills, prior to performing complex tasks on patients, with the goal of reducing potential errors and providing a safer procedure for the patient. The investigators will use a novel approach to simulation (patient-specific rehearsals) i.e., practice a short time prior to the live event that uses gel models of organs created by a 3D printer, and that are specific to each patient versus models that represent an ideal training model. The investigators' overarching goals are to improve patient outcomes by developing the best platform for surgeons to efficiently enhance performance prior to live surgery.
Primary Outcome
Fluoroscopy time is reported on completion of PCNL, the metric will be measured in minutes as a continuous variable.
Conditions Studied
Interventions
- OTHER Patient-specific simulated rehearsals
- OTHER Idealized simulated rehearsals
- OTHER Standard simulation
Study Locations (1)
New York
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2018-04-10 |
| Est. Completion | 2023-01-31 |
What the finished NCT03272529 record still lists
NCT03272529 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 36 participants, a relatively small participant target.
The record links to 1 condition, with Nephrolithotomy appearing as the primary indexed condition, and to 3 interventions - of which Patient-specific simulated rehearsals is the first listed.
NCT03272529 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03272529 about?
NCT03272529 is a clinical study titled "Simulated Rehearsal for Percutaneous Nephrolithotomy". Surgical simulation provides opportunities for surgeons to practice specific skills, prior to performing complex tasks on patients, with the goal of reducing potential errors and providing a safer procedure for the patient. The investigators will use a novel approach to simulation (patient-specific ...
What is the current status of trial NCT03272529?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2018-04-10. Estimated completion is 2023-01-31.
What conditions does trial NCT03272529 study?
This clinical trial studies the following conditions: Nephrolithotomy.
What interventions are being tested in trial NCT03272529?
The interventions under investigation include: Patient-specific simulated rehearsals (OTHER), Idealized simulated rehearsals (OTHER), Standard simulation (OTHER).
Who is sponsoring clinical trial NCT03272529?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03272529 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nephrolithotomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI